Vivos Therapeutics (NASDAQ:VVOS) reported quarterly losses of $(0.26) per share. This is unchanged from the same period last year. The company reported quarterly sales of $4.25 million which beat the analyst consensus estimate of $3.72 million by 14.14 percent. This is a 6.60 percent decrease over sales of $4.55 million the same period last year.
Pebblebrook Hotel Q2 EPS $0.12 Beats $0.09 Estimate
Pebblebrook Hotel (NYSE:PEB) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.09 by 33.33 percent. This is a 200 percent increase over losses of $(0.12) per share from the
